Friday, April 26, 2024

Training | 2016.07.19

ProMIS Neurosciences Announces New Program to Identify Novel ALS Disease Targets on Toxic Strains of Protein TDP43

ProMIS will host a webinar on Wednesday, July 20th to discuss the Company's recent progress, followed by Q&A session with Dr. Elliot Goldstein, ProMIS’ CEO, and Dr. Neil Cashman, ProMIS’ CSO.

(PRWeb July 19, 2016)

Read the full story at http://www.prweb.com/releases/2016/07/prweb13552944.htm

 

For more information, please visit
http://www.prweb.com/releases/2016/07/prweb13552944.htm

You need to login to post comments.

Feed last updated 2024/04/30 @5:04 AM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News